Swiss TPH study nurses taking blood from a study participant for the antibody test. Photo: Layla Hasler, Swiss TPH
Swiss TPH study nurses taking blood from a study participant for the antibody test. Photo: Layla Hasler, Swiss TPH - In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population. Therefore, seroprevalence has markedly increased since autumn of last year. Furthermore, the COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) is now publishing preliminary results regarding the effects that the pandemic and the measures implemented to contain it are having on the well-being and lifestyles of the population for the first time. As part of the Switzerland-wide research programme Corona Immunitas, the COVCO-Basel study is investigating the spread of SARS-CoV-2 in the population. In addition, the COVCO-Basel study is also investigating the effects of the containment measures on the well-being of population in the cantons of Basel-Stadt and Basel-Landschaft. The researchers at Swiss TPH have evaluated the effects of the pandemic for the time period between July 2020 and January 2021 and are now also able to present the latest results regarding the distribution of antibodies (seroprevalence) up to March 2021.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
